The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Changing patterns and trends in systemic fungal infections
Abstract
Invasive mycoses are a significant and growing public health problem. Although bloodstream infections with Candida albicans may be decreasing in frequency, the number of persons at risk for them continues to grow. Moreover, infections with other Candida species, such as Candida glabrata, are increasing in incidence. Invasive mould infections in general, and Aspergillus infections in particular, are becoming more frequent. Fungal opportunistic infections in persons with AIDS are no longer a major problem in developed countries, but are resulting in significant morbidity and mortality in developing countries with AIDS epidemics. Further studies are needed to define populations at very high risk for fungal opportunistic infections who might benefit from targeted antifungal chemoprophylaxis, which remains the most promising of the potential prevention strategies. This review highlights the changing patterns in risk factors, changes in epidemiology, the impact of changes in medical practice in intensive care and organ transplantation on the incidence of systemic fungal infections, and gives an overview of fungal infections in paediatric patients, patients with haematological malignancy, and the emergence of antifungal resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stoll, B. J., Hansen, N., Fanaroff, A. A., Wright, L. L., Carlo, W. A., Ehrenkranz, R. A., Lemons, J. A., Donovan, E. F., Stark, A. R., Tyson, J. E., et al. (2002) · Pediatrics · doi:10.1542/peds.110.2.285 · Cited by 2,355
Ascioglu, S., Rex, J. H., de Pauw, B., Bennett, J. E., Bille, J., Crokaert, F., Denning, D. W., Donnelly, J. P., Edwards, J. E., Erjavec, Z., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/323335 · Cited by 2,331
Stoll, B. J. (2004) · JAMA · doi:10.1001/jama.292.19.2357 · Cited by 1,533
Epidemiology and Outcome of Mould Infections in Hematopoietic Stem Cell Transplant Recipients
Marr, K. A., Carter, R. A., Crippa, F., Wald, A., & Corey, L. (2002) · Clinical Infectious Diseases · doi:10.1086/339202 · Cited by 1,448
Attributable Mortality of Nosocomial Candidemia, Revisited
Gudlaugsson, O., Gillespie, S., Lee, K., Berg, J. V., Hu, J., Messer, S., Herwaldt, L., Pfaller, M., & Diekema, D. (2003) · Clinical Infectious Diseases · doi:10.1086/378745 · Cited by 1,140
Epidemiology of Candida species infections in critically ill non-immunosuppressed patients
Eggimann, P., Garbino, J., & Pittet, D. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00801-6 · Cited by 900
Candida Colonization and Subsequent Infections in Critically III Surgical Patients
Pittet, D., Monod, M., Suter, P. M., Frenk, E., & Auckenthaler, R. (1994) · Annals of Surgery · doi:10.1097/00000658-199412000-00008 · Cited by 798
Benjamin, D. K., Stoll, B. J., Fanaroff, A. A., McDonald, S. A., Oh, W., Higgins, R. D., Duara, S., Poole, K., Laptook, A., Goldberg, R., et al. (2006) · Pediatrics · doi:10.1542/peds.2004-2292 · Cited by 667
Risk factors for candidemia in Neonatal Intensive Care Unit patients
SAIMAN, L., LUDINGTON, E., PFALLER, M., RANGEL-FRAUSTO, S., WIBLIN, T. R., DAWSON, J., BLUMBERG, H. M., PATTERSON, J. E., RINALDI, M., EDWARDS, J. E., et al. (2000) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200004000-00011 · Cited by 587
Fluconazole prophylaxis against fungal colonization and infection in preterm infants.
Kaufman, D., Boyle, R., Hazen, K. C., Patrie, J. T., Robinson, M., & Donowitz, L. G. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010494 · Cited by 523
Cited by
Cornely, O. A., Maertens, J., Bresnik, M., Ebrahimi, R., Ullmann, A. J., Bouza, E., Heussel, C. P., Lortholary, O., Rieger, C., Boehme, A., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/514341 · Cited by 751
The mycobiota: interactions between commensal fungi and the host immune system
Underhill, D. M., & Iliev, I. D. (2014) · Nature Reviews Immunology · doi:10.1038/nri3684 · Cited by 695
Antifungal Drug Development: Challenges, Unmet Clinical Needs, and New Approaches
Roemer, T., & Krysan, D. J. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019703 · Cited by 593
Combination antifungal therapy
Johnson, M. D., MacDougall, C., Ostrosky-Zeichner, L., Perfect, J. R., & Rex, J. H. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.3.693-715.2004 · Cited by 541
Changing epidemiology of systemic fungal infections
Richardson, M., & Lass-Flörl, C. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.01978.x · Cited by 524
Self-citationLu, J., Wang, Y., Jin, M., Yuan, Z., Bond, P., & Guo, J. (2020) · Water Research · doi:10.1016/j.watres.2019.115229 · Cited by 380
The changing face of epidemiology of invasive fungal disease in Europe
Lass‐Flörl, C. (2009) · Mycoses · doi:10.1111/j.1439-0507.2009.01691.x · Cited by 369
Falagas, M. E., Roussos, N., & Vardakas, K. Z. (2010) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2010.04.006 · Cited by 346
A nuclear receptor-like pathway regulating multidrug resistance in fungi
Thakur, J. K., Arthanari, H., Yang, F., Pan, S.-J., Fan, X., Breger, J., Frueh, D. P., Gulshan, K., Li, D. K., Mylonakis, E., et al. (2008) · Nature · doi:10.1038/nature06836 · Cited by 343
Pediatric Invasive Aspergillosis: A Multicenter Retrospective Analysis of 139 Contemporary Cases
Burgos, A., Zaoutis, T. E., Dvorak, C. C., Hoffman, J. A., Knapp, K. M., Nania, J. J., Prasad, P., & Steinbach, W. J. (2008) · Pediatrics · doi:10.1542/peds.2007-2117 · Cited by 343
Clinical Appearance of Oral Candida Infection and Therapeutic Strategies
Patil, S., Rao, R. S., Majumdar, B., & Anil, S. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.01391 · Cited by 324
Aspergillus fumigatus and Related Species
Sugui, J. A., Kwon-Chung, K. J., Juvvadi, P. R., Latge, J.-P., & Steinbach, W. J. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019786 · Cited by 278
Karkowska-Kuleta, J., Rapala-Kozik, M., & Kozik, A. (2009) · Acta Biochimica Polonica · doi:10.18388/abp.2009_2452 · Cited by 253
Cappelletty, D., & Eiselstein‐McKitrick, K. (2007) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.27.3.369 · Cited by 205
Erg11 mutations associated with azole resistance in clinical isolates of Candida albicans
Xiang, M.-J., Liu, J.-Y., Ni, P.-H., Wang, S., Shi, C., Wei, B., Ni, Y.-X., & Ge, H.-L. (2013) · FEMS Yeast Research · doi:10.1111/1567-1364.12042 · Cited by 197
Efflux pump proteins in antifungal resistance
Prasad, R., & Rawal, M. K. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00202 · Cited by 173
“The occurrence of fungal infections has risen dramatically over the past few decades because of the increase in number of immunocompromised patients undergoing, transplantation surgery, cancer chemotherapy and having an HIV infection etc. (Richardson, 2005).”
BackgroundWarrilow, A. G. S., Hull, C. M., Parker, J. E., Garvey, E. P., Hoekstra, W. J., Moore, W. R., Schotzinger, R. J., Kelly, D. E., & Kelly, S. L. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03707-14 · Cited by 173
Vandeputte, P., Tronchin, G., Larcher, G., Ernoult, E., Bergès, T., Chabasse, D., & Bouchara, J.-P. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00423-08 · Cited by 117
Azole Binding Properties of Candida albicans Sterol 14-α Demethylase (CaCYP51)
Warrilow, A. G. S., Martel, C. M., Parker, J. E., Melo, N., Lamb, D. C., Nes, W. D., Kelly, D. E., & Kelly, S. L. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00587-10 · Cited by 112
Candida albicans biofilm formation is associated with increased anti‐oxidative capacities
Seneviratne, C. J., Wang, Y., Jin, L., Abiko, Y., & Samaranayake, L. P. (2008) · PROTEOMICS · doi:10.1002/pmic.200701097 · Cited by 104
Burden of serious fungal infection in Nigeria.
(2014) · PubMed · Cited by 62
Warrilow, A. G., Nishimoto, A. T., Parker, J. E., Price, C. L., Flowers, S. A., Kelly, D. E., Rogers, P. D., & Kelly, S. L. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02586-18 · Cited by 60
“Controlling invasive fungal infections among oncology, hematology, and intensive care patients is a growing concern (7).”
Gregori, C., Schüller, C., Roetzer, A., Schwarzmüller, T., Ammerer, G., & Kuchler, K. (2007) · Eukaryotic Cell · doi:10.1128/ec.00106-07 · Cited by 57
“albicans (15, 35), accounting for about 20% of all systemic diseases caused by Candida spp.”
BackgroundChanging epidemiology of candidemia in a medical center in middle Taiwan
Hii, I.-M., Chang, H.-L., Lin, L.-C., Lee, Y.-L., Liu, Y.-M., Liu, C.-E., Chen, C.-H., Cheng, Y.-R., & Chang, C.-Y. (2015) · Journal of Microbiology, Immunology and Infection · doi:10.1016/j.jmii.2013.08.017 · Cited by 56
Araujo, J. T. C. D., Martin-Pastor, M., Pérez, L., Pinazo, A., & Sousa, F. F. O. D. (2021) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2021.115808 · Cited by 46
Bojsen, R., Regenberg, B., Gresham, D., & Folkesson, A. (2016) · Scientific Reports · doi:10.1038/srep21874 · Cited by 42
Candida Efflux ATPases and Antiporters in Clinical Drug Resistance
Prasad, R., Rawal, M. K., & Shah, A. H. (2016) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-25304-6_15 · Cited by 30
Nanotechnology-Based Strategies to Combat Multidrug-Resistant Candida auris Infections
Hetta, H. F., Ramadan, Y. N., Al-Kadmy, I. M. S., Ellah, N. H. A., Shbibe, L., & Battah, B. (2023) · Pathogens · doi:10.3390/pathogens12081033 · Cited by 24
Butts, A., Reitler, P., Ge, W., Fortwendel, J. R., & Palmer, G. E. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00504-18 · Cited by 14
McMahon, C. L., Esqueda, M., Yu, J.-J., Wall, G., Romo, J. A., Vila, T., Chaturvedi, A., Lopez-Ribot, J. L., Wormley, F., & Hung, C.-Y. (2023) · Journal of Fungi · doi:10.3390/jof9070722 · Cited by 13
Metadata
- Authors
- Richardson, M. D.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-09-01
- Volume
- 56
- Issue
- suppl_1
- Pages
- i5-i11
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2116830693
- Cited by
- 525
- References
- 78
- FWCI
- 21.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.